Boardroom Alpha
Meeting calendar
XPO · Annual meeting · Tuesday, May 19, 2026

Xpo Inc

7 nominees · 3 ballot items.

Elect seven directors; ratify KPMG LLP as independent auditor for fiscal 2026; and an advisory (non-binding) vote to approve the executive compensation disclosed in the proxy.

Market cap
$25.2B
1Y TSR
+56.4%
Board grade
A-
Record date
Mar 27, 2026
Filing
DEF 14A
Meeting concluded · May 19, 2026

Follow how the vote landed and what changed on Xpo Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    To elect seven members of the Board of Directors to serve until the 2027 Annual Meeting or until their successors are duly qualified and elected.

  2. 2

    Ratification of the Appointment of KPMG LLP as our Independent Registered Public Accounting Firm for Fiscal Year 2026

    ManagementBoard: FOR

    To ratify the appointment of KPMG LLP as the company’s independent registered public accounting firm for fiscal year 2026.

  3. 3

    Advisory Vote to Approve Executive Compensation

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the company’s named executive officers as disclosed in the Proxy Statement.

    More detail

    This proposal asks stockholders to cast a non-binding 'say-on-pay' vote to approve the compensation disclosed for XPO’s named executive officers. Management is seeking this advisory approval to validate its pay-for-performance framework and to demonstrate stockholder support for the design and outcomes of its executive pay program. The company’s program is heavily weighted toward at-risk compensation (short-term cash incentives and multi-year performance-based PSUs) and ties a large portion of pay to LTL adjusted EBITDA growth, LTL adjusted operating-ratio improvement, and relative TSR vs. the S&P Transportation Select Industry Index, supplemented by time-based RSUs for retention. The Compensation and Human Capital Committee emphasizes alignment with stockholder interests through stock ownership guidelines, clawback provisions, no hedging/pledging policies, and independent consultant benchmarking. The filing highlights strong recent stockholder support—say-on-pay received 99% support in 2025—and management states it has refined compensation in response to engagement with investors. The vote is advisory and non-binding, but the Board will consider the result when setting future compensation policies and awards. The Board recommends a vote FOR because it believes the program incentivizes the right operational priorities (profitability, network efficiency, TSR) while supporting retention of executive talent needed to execute XPO’s LTL growth strategy. In evaluating the proposal an analyst should weigh the specific performance metrics and multi-year PSU design against realized outcomes, such as the company’s 2023–2025 PSU achievement and recent adjusted EBITDA and operating-ratio improvements, and consider whether the at-risk structure and governance features sufficiently protect stockholder interests.

Director elections

Nominees on the ballot7

Not independent
Tenure on this board
3.7 yrs
Also a director at
Qxo Inc (QXO)
Independent
Tenure on this board
14.9 yrs
Also a director at
Centurion Acquisition Corp (ALF)
Independent
Tenure on this board
5.0 yrs
Also a director at
Qxo Inc (QXO)
Ownership

Top institutional holders10

Latest 13F quarter
1MFN Partners Management, LP9.7%11,425,369$2.2B
2Capital Research Global Investors8.2%9,588,191$1.9B
3BlackRock, Inc.5.6%6,547,179$1.3B
4Capital World Investors4.9%5,778,228$1.1B
5VANGUARD CAPITAL MANAGEMENT LLC4.3%5,060,285$984M
6VANGUARD PORTFOLIO MANAGEMENT LLC4.0%4,746,471$923M
7STATE STREET CORP3.1%3,582,960$697M
8BlackRock, Inc.2.9%3,426,534$667M
9Orbis Allan Gray Ltd2.7%3,214,924$625M
10FMR LLC2.6%3,074,961$598M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Xpo Inc 2026 annual meeting?
Xpo Inc (XPO) holds its 2026 annual shareholder meeting on Tuesday, May 19, 2026.
What is the record date for the Xpo Inc 2026 meeting?
The record date for the Xpo Inc 2026 meeting is Friday, March 27, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Xpo Inc's 2026 meeting?
The board is presenting 7 director nominees at the Xpo Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Xpo Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Xpo Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer